In This Article:
-
EBITDA Growth: Increased by more than 50% in Q1 compared to the prior year.
-
Free Cash Flow: Outgrew the prior year level by more than 50% in Q1.
-
Sales Record: Achieved an all-time sales record in Q1.
-
Net Savings: High double-digit million additional net savings expected.
-
Energy Costs: Expected to be lower due to hedges and decreasing spot energy prices.
-
Animal Nutrition Business: Continues strong performance with tight market conditions and strong demand.
-
Global GDP Growth Expectation: Revised down to 2.2% for 2025 from 2.5%.
Release Date: May 12, 2025
For the complete transcript of the earnings call, please refer to the full earnings call transcript.
Positive Points
-
Evonik Industries AG (EVKIF) reported a more than 50% increase in free cash flow in Q1 compared to the previous year.
-
The company confirmed its full-year guidance, supported by strong Q1 performance and a solid start to Q2.
-
Evonik's resilient businesses in specialty additives and strong growth in nutrition and care differentiate its portfolio from peers.
-
Cost programs are in full execution, supporting solid operating performance.
-
High local production presence shields the company from protectionism and offers opportunities behind tariff borders.
Negative Points
-
Global GDP growth expectations for 2025 have been lowered to 2.2%, down from 2.5% two months ago.
-
Foreign exchange is turning from a tailwind into a headwind, impacting financial performance.
-
There is increased uncertainty due to potential trade and tariff tensions, which could affect customer and end consumer confidence.
-
The C4 business is experiencing macroeconomic challenges with decreasing naphtha and butadiene prices.
-
Visibility remains low, with no significant macro slowdown yet, but potential risks such as a global recession are being monitored.
Q & A Highlights
Q: How does Evonik Industries AG plan to benefit from the upcoming infrastructure spending initiative in Germany, and what impact might Chinese exports have on the European market due to tariffs? A: Christian Kullmann, Chairman of the Executive Board, stated that the new German government is focused on making Germany and Europe attractive for the chemical industry by 2045. Evonik expects to benefit from lower energy prices and infrastructure programs, particularly in construction-related businesses. Regarding Chinese exports, Maike Schuh, CFO, noted that while there might be increased competition in crosslinkers, the impact on other products like methionine, silica, and hydrogen peroxide is expected to be limited due to Evonik's local production capabilities.